Organon Of The Medical Art Pdf
Beverly Friddle
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey.[4] Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but gets a third of its revenue from the United States. Organon & Co. is an example of increasing women's representation on Wall Street with over 50% of its board of directors and executive leadership being female.[5]
Organon was founded in 1923 as a partnership between the physiologist/endocrinologist of the University of Amsterdam Prof Ernst Laqueur and Saal van Zwanenberg (1889-1974)[6] who owned an abattoir/slaughterhouse, Zwanenbergs Slachterijen en Fabrieken, in Oss in Northern Brabant. The company's first product was insulin in 1923.[7] In the thirties it manufactured estrogens, in particular estrone under the trade name Menformon.[7]
In 1962, it bought the stock of the Nederlandsche Cocanefabriek. The company name was changed to Koninklijke Zwanenberg-Organon (KZO), and it merged with the fibre producer AKU in 1969 to become AKZO, later Akzo Nobel. Organon was the human health care business unit of Akzo Nobel. In 2004, Organon acquired active-pharmaceutical-ingredient producer Diosynth.[8]
Organon was initially located in West Orange, New Jersey.[9][10][11] In November 2007, Schering-Plough acquired Organon BioSciences and veterinary pharmaceutical company Intervet from Akzo Nobel.[12] Schering-Plough transferred Organon to its headquarters in Jersey City, New Jersey.[13] Two years later, Schering-Plough merged with Merck & Co., known as Merck Sharp & Dohme or MSD outside the United States and Canada.[14]
Their products are divided into three main categories women's health (27% of revenue), biosimilars (8% of revenue), and established brands (64% of revenue). Women's health products are mainly contraceptives such as Nexplanon, a three-year reversible contraceptive implant, and fertility drugs such as Puregon, a follicle-stimulating hormone drug.[5] Biosimilars provide treatment for oncology and immunology at potentially lower cost than other FDA approved treatments.[5][20] Organon makes the biosimilar Hadlima which it compares to Humira. Their established brands are heavily reliant on sales outside the United States of drugs with generic competition. The cardiovascular products such as Vytorin make a combined 24% of the company revenue.[5] Revenue figures stated with 2022 figures.
During its period of independent operation, Organon developed a large number of compounds which were never adopted for medical use, but continue to be used for a variety of scientific research. Notable compounds include:
In 2007, whistleblower lawsuits were filed against Organon in federal courts in Massachusetts and Texas. Organon was accused of selling its anti-depression medication Remeron at a discount to nursing home pharmacies (in order to encourage use), yet filing claims to Medicare for reimbursement at the full, undiscounted price. Organon agreed to settle the case for $31 million in October 2014.[21]
In this role, he/she oversees the strategies and execution of activities related to Medical Review of (non-)promotional materials and medical information for the cluster. He/she supervises and leads a team with people dedicated to medical review and/or medical information, in compliance with the applicable rules and procedures, and ensures the development of their skills and knowledge.
Ensure management and quality control of the vendor that performs the DPOC service; this includes the receipt of cases (i.e. medical information requests, adverse events, product quality complaints), the classification, and appropriate routing of cases for further processing to meet regulatory and business requirements.
Manage the processes related to medical information (i.e. response to or triage of unsolicited on-label and off-label inquiries received from healthcare providers and other external and internal stakeholders).
We prioritize our patients first through listening, learning and understanding their needs. As the biosimilar landscape changes, we see the growing need to support education for healthcare professionals to continue their learning about biosimilars across therapeutic areas including:
Our Company supports IME initiatives grounded in learning, data, behavioral, and implementation sciences. Grant funding can only be provided to eligible organizations and not to individual healthcare professionals. Eligible organizations may include hospitals, academic medical centers, medical schools, professional medical associations/societies, and medical education companies.
Please read the Medication Guide for RENFLEXIS, including the information about serious infections and cancers, and discuss it with your doctor. The physician Prescribing Information also is available.
This private and confidential program provides product free of charge to eligible individuals, primarily the uninsured, who, without our assistance, could not afford needed Organon medicines. A single application may provide for up to 1 year of product free of charge to eligible individuals and an individual may reapply as many times as needed.
Referrals from The Organon Access Program to the Organon Patient Assistance Program are primarily designed to help those who do not have insurance coverage; however, if you have insurance coverage, but still are having trouble paying for your medicine, you may still be eligible, provided that your income is not above a set limit and you meet certain other medical and/or insurance criteria.
To apply for the Organon Patient Assistance Program for RENFLEXIS, you must complete an Enrollment Form for The Organon Access Program. The Organon Access Program provides support to help answer questions related to insurance coverage and reimbursement.
You and your health care provider can call The Organon Access Program at 866-847-3539 to request an enrollment form. The Organon Access Program Representatives are available 8 AM to 8 PM ET, Monday through Friday, to answer questions about the program.
The ongoing phase 2 clinical ELENA trial of OG-6219 assesses the efficacy, safety, and tolerability of three different doses of the compound in pre-menopausal women between the ages of 18 to 49 who have been surgically diagnosed with moderate to severe endometriosis-related pain.
In early November, the company unveiled an alliance with Sempre Health to motivate eligible patients to refill prescriptions for Dulera (mometasone furoate, formoterol fumarate dihydrate) and Asmanex (mometasone furoate), which are for asthma.
As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.
Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbu...@wtwhmedia.com.
Copyright 2024 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy Advertising About Us
Mosca D. PRESS RELEASE: 3D Orga-non, the most advanced extended reali-ty (XR) medical anatomy platform. Great tool for remote delivery teaching. [Internet]. Media Database; 2020 [cited 15 Jun 2021]. .
3D Organon VR Anatomy is a medical anatomy software which contains detailed 3D anatomy models of the male and female human body including the Reproductive and Integumentary (skin) systems.
All 3D models in the software are designed under the supervision of anatomy professors and medical professionals.
Written by Samuel Hahnemann, the founder of homeopathy, The Organon of Medicine is the cornerstone of homeopathic principles and practice, and used by homeopathy students and practitioners. We provide this important book here free of charge and in digital format, so that it can be enjoyed by all interested in homeopathy.
From the cover
The Organon developed slowly out of Hahnemann's research and experimentation over a period of time. It underwent as many as six editions. This sixth edition incorporates the latest findings of Dr Hahnemann during his dying years and deemed to be the most perfect of all. Many newer concepts like replacement of the vital force by vital principle, the 50th millesimal scale of potency and permissibility of external applications were introduced for the first time, which were unheard of in the other editions. The work is a result of the untiring effects of the master to improve and update his work and is of historical importance as far as the medical philosophy is concerned. It is the high water mark of medical philosophy, the practical interpretation of which produces a veritable mountain of light and guides the physician by means of the law of cure to a new world in therapeutics.